Therefore, we undertook a series of studies in vitro and in HCC-bearing nude mice to explore the specific mechanisms of CCAT1 in HCC with the involvement of SOX2, EGFR, miR-222-5P and CYLD. This evidence concerns the gene CYLD and hepatocellular carcinoma.